BASALOG Insulin Glargine Injection (rDNA Origin) 100 IUmL ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

basalog insulin glargine injection (rdna origin) 100 iuml

biocon sdn bhd - insulin glargine -

ZUHERA Trastuzumab for Injection (rDNA Origin) 150mgvial ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuhera trastuzumab for injection (rdna origin) 150mgvial

biocon sdn bhd - trastuzumab -

ZUHERA Trastuzumab for Injection (rDNA Origin) 440 mgvial ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuhera trastuzumab for injection (rdna origin) 440 mgvial

biocon sdn bhd - trastuzumab -

BASALOG Insulin Glargine Injection (rDNA Origin) 100 IUmL ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

basalog insulin glargine injection (rdna origin) 100 iuml

biocon sdn bhd - insulin glargine -

Basalog One Insulin Glargine Injection (rDNA Origin) 100 IUmL Prefilled Pen ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

basalog one insulin glargine injection (rdna origin) 100 iuml prefilled pen

biocon sdn bhd - insulin glargine -

BASALOG ONE Insulin Glargine Injection (rDNA origin) 100IUmL Prefilled Pen ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

basalog one insulin glargine injection (rdna origin) 100iuml prefilled pen

biocon sdn bhd - insulin glargine -

BASALOG 100 IUmL SOLUTION FOR INJECTION IN A VIAL ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

basalog 100 iuml solution for injection in a vial

biocon sdn bhd - insulin glargine -

BASALOG Insulin Glargine Injection (rDNA Origin) 100 IUmL (Vials) ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

basalog insulin glargine injection (rdna origin) 100 iuml (vials)

biocon sdn bhd - insulin glargine -

OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

ogivri™ lyophilized powder for injection 440mg per vial

zuellig pharma pte. ltd. - (powder) trastuzumab - injection, powder, lyophilized, for solution - (powder) trastuzumab 440 mg/vial

HERITY إسرائيل - الإنجليزية - Ministry of Health

herity

unipharm trading ltd, israel - trastuzumab - powder and solvent for concentrate for solution for infusion - trastuzumab 420 mg/vial - trastuzumab - herity is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress her2:1. as a single agent for the treatment of those patients who have received one or more chemotherapy regiments for their metastatic disease.2. in combination with paclitaxel or docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease.3. herity in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive metastatic breast cancer.early breast cancer (ebc) :herity is indicated to treat patients with her2-positive early breast cancer following surgery and chemotherapy (neoadjuvant or adjuvant) either alone or in combination with chemotherapy excluding anthracyclines.herity should only be used in patients whose tumors have either her2 overexpression or her2 gene amplification as determined by an accurate and validated assay.her2 metastatic gastric cancer (mgc). herity in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of patients with her2 positive metastatic adenocarcinoma of the stomach or gastro-esophageal junction who have not received prior anti-cancer treatment for their metastatic disease.herity should only be used in patients with metastatic gastric cancer whose tumours have her2 overexpression as defined by ihc2+ and a confirmatory fish+ result, or ihc 3+, as determined by an accurate and validated assay.